← Back to all trials
Not Yet Recruiting
NCT07852962
Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.
Conditions: Healthy Volunteers
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 10
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to assess the drug levels, immune response, safety and tolerability of BMS-986446 in healthy Chinese participants.
Eligibility Criteria
Inclusion Criteria:
* Participants must be of Chinese ethnicity (both biological parents are ethnically Chinese).
* Participants must be Healthy adult male and female (as assigned at birth and non-pregnant and non-nursing).
* Participants must have BMI of 18.0 to 28.0 kg/m2.
Exclusion Criteria:
* Participants must not have general history of any clinically significant gastrointestinal, renal, hepatic, bronchopulmonary, neurological, psychiatric, cardiovascular, endocrinological, immune-mediated, or hematological disorder; allergic disease; metabolic disorder; cancer; or cirrhosis.
* Other protocol-defined Inclusion/Exclusion criteria apply.
Source: ClinicalTrials.gov (NCT07852962). StuddyBuddy aggregates publicly available trial information.
